A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
Clinical trial NCT07312773 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07312773
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-23
- Primary completion
- 2026-02-07
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.